Literature DB >> 6364917

[Treatment of scleroderma].

L Guillevin, J P Ortonne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6364917

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN： 0003-410X


× No keyword cloud information.
  4 in total

1.  5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.

Authors:  J A Casas; P A Saway; I Villarreal; C Nolte; B L Menajovsky; E E Escudero; W D Blackburn; G S Alarcón; C P Subauste
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

2.  Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).

Authors:  C Georges; O Chassany; L Mouthon; K Tiev; C Toledano; O Meyer; Z Marjanovic; C Heneggar; T Papo; B Crickx; D Sereni; J Cabane; D Farge
Journal:  Clin Rheumatol       Date:  2004-06-23       Impact factor: 2.980

3.  A new promising treatment in systemic sclerosis: 5-fluorouracil.

Authors:  J A Casas; C P Subauste; G S Alarcón
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

4.  Interventions for morphea.

Authors:  Julia V de Albuquerque; Brenda Ng Andriolo; Monica Ra Vasconcellos; Vinicius T Civile; Anne Lyddiatt; Virginia Fm Trevisani
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.